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PETER JACOBS, t M.D. (RAND), F.C.P. (S.A.), Research Assistant, Department of Medicine, University of the Wit-
watersrand, Johannesburg, AND Roy ROBINSON, F.LM.L.T., Department of Bacteriology, South African Institute for
Medical Research, Johannesburg
Acute bacterial infection of the respiratory tract, arising
either de novo or superimposed upon chronic chest disease,
constitutes a major cause of morbidity and mortality. This
problem is particularly severe in the winter months when
an additional burden is placed on practitioners and hospi-
tals alike, and is aggravated by the variety of pathogens
encountered and the frequent emergence of resistant
strains.
In an attempt to meet the challenge of bacterial mutation
and drug resistance, new antibacterial agents are con-
tinuously marketed, each accompanied by claims that it
possesses one or more advantages over those already in
use. The majority of these drugs are carefully tested before
their release; however, responsibility remains with those
physicians using them, to further evaluate each agent in an
attempt to define the incidence and significance of disad-
vantages and complications.
It is against this background that we have recently ad-
ministered a new tetracycline antibiotic, doxycycline
(Vibramycin), to a group of patients with acute respiratory
tract infections, admitted to Johannesburg Hospital.
Doxycycline, chemically known as alpha-6-deoxyoxy-
tetracycline, is a long-acting tetracycline antibiotic which
is almost completely absorbed following oral administra-
tion,' is minimally influenced by the simultaneous adminis-
tration of food,' has a long serum half-life,' and is said to
attain high tissue levels:
These interesting experimental observations, coupled
with previous clinical studies:" suggested that doxycycline
may have a place in the treatment of respiratory tract
infection, particularly in those patients who find it incon-
venient or who cannot be relied upon to take large
numbers of tablets throughout the day. Accordingly, this
study was undertaken to further document the clinical
response of patients with acute bacterial respiratory tract
infection and, in view of the long half-life, to examine the
possibility that a build-up of serum antibiotic concentra-
tion might be taking place during a full course of therapy.
At the same time, laboratory studies were planned to
define serum and urine levels and to establish a minimum
inhibitory concentration of doxycycline against the patho-
gens encountered.
MATERIAL AND METHODS
Thirty patients with acute respiratory tract infections were
studied. In the majority of these there was underlying
chronic chest disease in the form of recurrent bronchitis,
with or without associated emphysema. Seven patients had
pneumonia arising without any history of preceding chest
infection, and 2 further patients suffered from uncompli-
cated bronchial asthma. The details of these patients are
set out in Table 1.
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On admission, sputum was collected from each patient
for culture and sensitivity studies. Immediately thereafter,
200 mg. of doxycycline was administered orally, followed
by 100 mg. every 24 hours for 5 days. In each instance the
antibiotic was given to the fasting patient. Where neces-
sary, therapy extended beyond the 5 days described in this
paper. Minimum inhibitory concentration (MIC) required
to prevent growth of bacteria for 24 hours at 37°C was
determined by serial tube dilution in I-ml. amounts of
brain-heart infusion broth. All serial dilution tubes were
inoculated with 0·02 ml. of an overnight broth culture
diluted I in 500.
Doxycycline concentrations were determined by the cup-
plate biological assay method; Bacillus cereus variant
mycoides ATCC 9634 served as the test organism. Brain-
heart infusion agar seeded with test organisms was poured
into large assay plates to give an agar depth of approxi-
mately 4 mm. Plugs of agar were removed to give holes
of 7 mm. diameter which were filled with the solutions to
be assayed. The plates were then incubated overnight at
300C. To compensate for variation in agar thickness, a
mirror technique was used, and all standards and samples
to be assayed were tested in duplicate holes diagonally
opposed to one another.
A standard solution of doxycycline was diluted to a
concentration of 8·0 f-lg./ml. in S!Drensen's phosphate buffer
solution M/15 at pH 4·5 and then in a diluent consisting
of 1 part 7% bovine albumin fraction V and 2 parts of
phosphate buffer to obtain a final concentration of 0·8;
0·4; 0·2 and 0·1 f-lg.fml.
Samples of serum were collected 3 hours after the initial
dose on day 1 and an hour before the next dose was due
to be administered on day 2. Further samples were col-
lected one hour before the drug was given on day 5.
Samples of serum and urine were kept in the deep-freeze
for a period not exceeding 5 days before assay. Upon
receipt, samples of urine were sterilized by passage through
a membrane filter. The sera were initially diluted 1 in 3
with phosphate buffer and further dilutions made with
albumin-phosphate buffered diluent to give final dilutions
of I in 6 and 1 in 12; the albumin content of these dilu-
tions was matched with that present in the standard. All
urine samples were diluted 1 in 40 and 1 in 80 with
phosphate buffer.
RESULTS
In each patient, response to therapy was assessed clinically,
by fall in temperature, by resolution in radiological
changes, by reduction in the volume of sputum produced
and by alteration in its quality (Table I). In 24 of our
patients the response, as judged by these criteria, was
either good or excellent. In 3 further subjects the response
was good, although somewhat slower than that seen in the
majority of the subjects studied. One patient died before
he could be assessed.
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Sex Clinical diagno5is Radiological findings growth pg.fml. Clinical response Sputum Comments
LOP Simple cbronic bronchitis No abnormality detected No specimens Excellent o sputum Very heavy smoker for
70 plus emphysema. Bilateral response. many years
M basal bronchopneumonia Temperature
elevated 24 hours
JPB Chronic simple bronchitis Extensive left basal Sraph. pyogenes 0·009 Excellent Purulent Very heavy smoker.
53 with superimposed acute consolidation Haemolytic 0·002 response. sputum Very heavy alcohol intake
M infection-left basal streptococcus 0·037 Temperature for 72 hours
pneumonia Strep. pneumoniae elevated 72 hours
FWO Simple chronic bronchitis. Partial resection righ t E. coli JO Excellent Purulent Previously known
54 Superimposed acute 6th rib. previous right Strep. viridans 1'25 response. sputum pulmonary tuberculosis
M bronchopneumonia upper lobectomy. Fibro- Haemolytic 0·20 Temperature for 24 hOlUS
tic changes at right base streptococcus elevated 24 hours
RG Chronic bronchitis plus Multiple abscesses ormal flora No response. Purulent No response to tetracycline
62 emphysema. located around the Temperature sputum --organisms insensitive.
M Multiple lung abscesses right hilum elevated 3 weeks for 3 weeks Following bronchoscopy
the patient responded
slowly to a long course of
Ceporan and gentamicin
LP Bilateral broncho- Extensive basal Tormal flora Excellent Purulent Cor pulmonale
92 pneumonia consolidation response. purum
F Temperature for 48 hours
elevated 48 hours
lOW Chronic mucopurulent Widespread and fre- Kleh. aerogenes 6·25 Slow over 2 weeks Purulent Myasthenia gravis.
62 bronchitis with quently changing signs of sputum Cor pulmonale
M emphysema. Superimposed bilateral pulmonary for 2-3 weeks,
diffuse acute bronchitis infection then 34 weeks
clear sputum
HK Bronchial asthma Hyperinflation only Scaph. albus 3'125 Excellent Purulent
72 E. coli 25 response. sputum
M Temperature for 24 hours
elevated 24 hours
PH Left lower lobe Left basal consolidation Normal flora Excellent Purulent Alcoholic cirrhosis
46 pneumonia response. sputum
F Temperature for 48 hours
elevated 36 hours
IVH Chronic simple bronchi lis Bilateral basal increased Strep. pneumoniae 0·037 Good response. Purulent
6 plus emphysema. bronchopulmonary Temperature sputum
F Superimposed acute markings elevated 4 days for 1 week
infection
JK Right lower lobe Consolidation of the No specimen Excellent No sputum
J5 pneumonia apical segment of the response.
M right lower lobe Temperature
e:evated 12 hours
WFK Chronic bronchitis with No abnormality detected Sraph. albus 5 Good response. Purulent Multiple pulmonary
74 superimposed acute Temperature sputum emboli. on anticoagulant
F infection elevated 4 days for 4 days therapy
LVB Acute right mid-zone Right middle lobe Normal flora Excellent Purulent Vertebrobasilar
75 pneumonia pneumonia response. sputum insufficiency
F Temperature for 72 hours
elevated 48 hours
Z Left basal branch0- Apical segment of left E. coli 2'5 Excellent Purulent
72 pneumonia lower lobe consolidated response. sputum
M No temperature for 24 hours
Two of the 30 patients failed to respond. In the one
individual, radiological evidence demonstrated the presence
of lung abscesses from which organisms sensitive only to
cephaloridine and gentamicin were isolated. Following
bronchoscopy and parenteral administration of these
agents, the patient made a slow return to health. In the
second subject, large numbers of different organisms have
been isolated and, 'despite the use of most of the commonly
available antibiotics, either singly or in combination, it has
been impossible to influence the course of this patient's
disease. At present, she remains chronically ill from per-
sistent chest infection with the continued production of
large amounts of purulent sputum.
During the course of study, half of the patients fulfilling
the criteria of acute respiratory tract infection were given
doxycycline. During the same period of time, a similar
number of patients with comparable conditions admitted
to the other half of the unit received antibiotics such as
ampicillin or combinations of penicil1in and streptomycin
or other tetracyclines in full therapeutic dosage. Although
no direct comparison was made between these groups,
clinical evidence and serial radiological studies indicated
that there was no appreciable difference in response be-
tween the 2 series of patients.
Serum concentrations of doxycycline 3 hours after an
initial dose of 200 mg. ranged from 0·8 to 7·8 /lg./ml., with
an average of 3-4 /lg./m1. (Fig. 1). During the next 20
hours there was a slow decline in the serum concentration,
with average levels of 2·5 p,g./ml. being present 23 hours
after the initial dose. Further assays after 5 days of therapy,
using the regimen outlined above, showed a similar range
of concentrations, again with an average of 2·5 /lg./mI.
(Fig. 1).
The average urine concentration of doxycycline 3 hours
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after the initial dose was 31·6 JLg. / ml., and this declined to
21·2 JLg./ml. after 23 hours. Fl,lJther assays after 5 days of
therapy gave average concentrations of 13·8 JLg./ml.
~ n~ 5~
Fig. 1. Doxycyline serum levels (I'g./ml.) 3 hours after
initial 200-mg. dose (A), I hour before second oral dose of
100 mg. (B) and I hour before IOO-mg. oral dose on day 5.
DISCUSSIO
Bacterial infections of the respiratory tract, although com-
monly associated with viral infections," frequently require
antibiotic therapy, and before any new agent gains accept-
ance it must be more effective, more convenient, cheaper
or safer than those previously used. Doxycycline, a stable
tetracycline derivative, has been demonstrated by this study
to be effective in treating this type of respiratory infection.
These findings are in agreement with those previously
reported by Gilgore and Migliardi' and Fabre and Hany."
There were, as expected, instances of individual variation
in absorption and excretion. Of interest was the one patient
in this series who had a 3-hour level of 0·8 JLg./ml. and in
whose urine, at this time, doxycycline could not be de-
tected. After 23 hours a concentration of 0·5 IJ-g./ml. was
obtained in the urine, while the serum concentration had
declined further to 0'1 p.g./ml. Serum and urine assays
5 days after therapy showed concentrations of 2·7 and 2·3
p.g.jml., respectively. In 4 other patients serum concen-
trations were higher 23 hours after the initial dose than
they were at 3 hours.
The 95% confidence limits, using the Student's Hest,
showed a 3-hour serum concentration range of 0·03 - 3·4 -
6·8 IJ-g./ml. After 23 hours this range had narrowed to
0·7 - 2·5 - 5·6 JLg.jml., and it remained relatively constant
after 5 days of therapy, when the limits were 0·5 - 2·5 - 5·5
JLg./ml. These findings suggest that there is not any build-
up of doxycycline in the serum after a full course of
therapy.
In addition, our experience sugge t that doxycycline ad-
ministered in the dosage defined above controls this type
of infection as well as ampicillin or tetracycline, or com-
binations of penicillin and streptomycin. A further 50
patients have subsequently received doxycycline. and clini-
cal response has, in each case, been good.' However, a
formal double-blind trial will be required to demonstrate
any statistical advantage of one drug over the other. In
comparing ampicillin and doxycycline, the higher co t of
the latter is offset, to some extent, by the fewer cap ule
required each day, and, excluding possible di comfort to
the patient and inconvenience of admini tration, little
difference in cost is likely to be present.
A previous studi has compared plasma level in ubject
given 100 mg. oral doxycycline in the fasting state with
levels obtained after 300 mg. demethylchlortetracycline and
contrasted these with the plasma levels obtained after
simultaneous administration of food. This study showed
that both drugs administered to the fasting patient resulted
in high blood levels, doxycycline reaching a peak of 1·8
p.g.jml. in 2 hours, and demethylchlortetracycline a peak
of 1·99 JLg./ml. at 4 hours. A decline of plasma concentra-
tions in both instances was slow, and a concentration of
more than 1 JLg./m!. was still present 12 hours after the
oral ingestion. Of central importance i the minimal effect
on plasma levels of doxycycline produced by food, a
opposed to the marked depression on demethylchlortetra-
cycline when studied under similar condition. Significantly,
15 m!. of antacid containing aluminium hydroxide adminis-
tered simultaneously with either drug resulted in negligible
blood levels.
Serum half-life of doxycycline in adults is 15'1 hours as
compared with 12·7 hours for demethylchlortetracycline.'
Other evidence has been citedS in which this value, calcu-
lated in premature infants during the fir t 3 weeks of life,
ranged between 14·5 and 23·5 hour with an average of
20·2 hours. The value of 2·5 JLg./ml. at 23 hours obtained
in this study is of some interest, ince it confirms that
doxycycline has a long half-life and may well exceed the
time reported by other worker.'" However, although
individual variation should be expected, it is not clear why
the 23-hour levels obtained in this study should show such
a degree of variation since the drug was, on each occasion,
administered to the patient in a fasting state.
Doxycycline is highly bound to serum protein' as are
other tetracyclines.' Thus, using a modified ultrafiltration
method described by Bennett and Kirby,'· figures of 93°"
were obtained for doxycycline, 91 o~ for demethyl hlortetra-
cycline and 64% for tetracycline.' Following 200 mg. of
doxycycline as an initial dose and 100 mg. every 24 hour
thereafter, crude tissue levels estimated on amples col-
lected during surgery were consistently greater than tho e
present in simultaneously collected blood samples, and
this was more obvious in specimens of lungs than in skele-
tal muscles.' Similar observations have been reported in
dogs." Although the measurement of tetracycline level on
tissues is difficult, these observations may have ignificance
regarding the effectiveness of doxycycline when used in
the treatment of bacterial infections of lung parenchyma.
It has been reported that there is no need to reduce the
level at which doxycycline is administered- orally in renal
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plasma levels or by detectable toxic effect on the liver or
the marrow: Although it is not clear why a drug like
doxycycline, which is excreted by the kidney and which
has a long half-life, should not accumulate when renal
function is disturbed, we believe that this feature is an
important one and requires further investigation. Confirma-
tion of these observations would suggest that doxycycline
has a specific place in the treatment of bacterial infections
accompanying renal insufficiency.
No side-effects were encountered in this study following
the administration of doxycycline as outlined above. It
might be anticipated that, with reduced calcium binding
and the low dosage required in the treatment of pulmonary
infection, staining of the teeth on long-term therapy may
be somewhat less of a problem.
Despite evidence that the spectrum of activity of doxy-
cycline is similar to that of other tetracyclines," our own
laboratory findings have demonstrated that an appreciable
number of fresh isolates of Staphylococcus pyogenes from
clinical material were sensitive to doxycycline when
examined, using sensitivity discs of 30-fLg. content, but less
so to tetracycline hydrochloride, using discs of 50-fLg·
content. Since differing diffusion characteristics of the
various tetracyclines make accurate comparisons by the
latter method difficult, these results were confirmed by
minimum inhibitory concentration studies, where at least
an 8 - IO-fold difference in favour of doxycycline was con-
sistently obtained. This trend, in lower minimum inhibitory
concentrations obtained with the latter agent, has also been
observed with Staphylococcus pyogenes strains sensitive to
both analogues when determined by the disc method.
It is generally accepted that the emergence of bacterial
drug resistance is due to mutants which have the ability to
grow in the presence of antibiotics and so confer upon
these emergent strains a selective advantage over the
sensitive organisms. If, during treatment of a patient, the
concentration of an antibiotic is allowed to drop below
its minimum inhibitory concentration, it may be speculated
that the organism will multiply, with the possibility that
drug-resistant mutants will occur. When therapeutic levels
are again achieved, the mutants will have developed a
selective advantage and so be able to maintain the infec-
tion. However, in any theoretical consideration of this
nature, it must be appreciated that bacteria have a well-
defined recovery phase before multiplication again takes
BOOK REVIEWS
place, and for this reason further sophisticated studies will
be necessary before specifically attributing to doxycycline,
with its extended half-life and slow decline in serum levels,
the' added role of reducing the emergence of antibiotic-
resistant mutants.
SUMMARY
Doxycycline has been administered to 30 patients with acute
pulmonary infection over a period of approximately one year.
In' all but 2 of the patients the clinical response to a loading
dose of 200 mg. a day and 100 mg. orally each day for 5 days
thereafter has proved eminently satisfactory. The clinical re-
sponse was paralleled by a fall in temperature and reduction in
the amount of sputum produced, and was supported in each case
by improvement shown on serial radiological studies. Bacterio-
logical studies characterized the offending organism and defined
minimum inhibitory concentrations of doxycycline required to
prevent growth. A long half-life is confirmed, yet no evidence
was obtained to suggest that this antibiotic accumulates signi-
ficantly in the plasma. 0 side-effects were encountered in this
study and it is concluded that, under these conditions, doxy-
cycline is an efficient and convenient antibiotic, particularly in
those patients where the number of tablets required daily is a
significant factor.
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van Wyk, Medical Superintendent of Johannesburg Hospital,
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BOEKBESPREKINGS
MALIGNE- E KOLLAGEEN-SIEKTES KONGE ITALE HARTLETSELS
Monoe/onal and Polye/onal Hypzrgammaglobulinemia. Clini-
cal and biological significance. By J. G. Waldenstrom. Pp.
vii + 222. Illustrated. Ss. Od. London: Cambridge University
Press. 1968.
Hierdie boek is besonder interessant vir biochemici, immunoloe,
seroloe en klinici wat met die diagnose en behandeling van
maligne- en kollageen-siektes belas is. Waldenstrom verduide-
lik die kliniese en biologiese belang van die immunoglobu-
liene op 'n voortreflike wyse. Die outeur het volkome beheer
oor die onderwerp en daarby ook 'n gooie en duidelike taal-
gebruik. Ingewikkelde reaksies word aan die hand van een-
voudige tekeninge verduidelik. Die book word aangevul deur
'n volledige bibliografie en 'n omvattende indeks. Papier- en
druk-kwaliteit is van hoe gehalte en die prys redelik. Hierdie
book kan as 'n gooie vakboek aanbeveel word. H.D.B.
The Surgery of the Common Congenital Cardiac Malforma-
lions. By e. N. Bamard, M.D., M.Med. (Cape Town), M.S.,
Ph.D. (Minnesota), F.A.e.S., F.A.e.C. and V. Sehrire, M.Se.,
Ph.D., M.D. (Cape Town), F.R.e.P.E., F.RC.P., FAe.e.
Pp. 179. Illustrated. £2.10.0. London: Staples Press. 1968.
Die chirurgiese behandeling van die mees algemene kongenitale
hartletsels word op 'n eenvoudige, saaklike en helder wyse
aangebied. Die sketse en diagramme is duidelik en vergemaklik
begrip. Dit is seker dat die skrywers uit hul eie wye ervaring
put; nogtans word 'n volledige lys van goeie verwysings na
die wereldliteratuur aangehaal. Die book word sterk ,!anbe-
veel en daar kan beslis uitgesien word na 'n tweede, vergrote
uitgawe waarin die chirurgiese behandeling van verworwe
hartletsels oak beskryf word.
G.P.H.
